• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内超声碎石术对冠状动脉顺应性的改善:钙化冠状动脉病变中支架扩张的新预测指标

Coronary Compliance Modification by Intravascular Lithotripsy: New Predictor of Stent Expansion in Calcified Coronary Lesions.

作者信息

Oliveri Federico, Van Oort Martijn J H, Al Amri Ibtihal, Bingen Brian O, Claessen Bimmer E, Dimitriu-Leen Aukelien C, Kefer Joelle, Girgis Hany, Vossenberg Tessel, Van der Kley Frank, Jukema J Wouter, Montero-Cabezas Josè M

机构信息

Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.

Department of Cardiology, Amsterdam University Medical Center, Amsterdam, the Netherlands.

出版信息

J Soc Cardiovasc Angiogr Interv. 2025 May 1;4(5):102635. doi: 10.1016/j.jscai.2025.102635. eCollection 2025 May.

DOI:10.1016/j.jscai.2025.102635
PMID:40454281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12126079/
Abstract

BACKGROUND

Intravascular lithotripsy IVL) has been demonstrated to be effective in treating balloon-crossable calcified coronary lesions by inducing calcium fractures and facilitating stent expansion (SE), theoretically by improving coronary artery compliance (CACom). Direct evidence of this theory has not yet been provided.

METHODS

From the BENELUX-IVL prospective registry (NCT06577038) enrolling patients with calcified coronary artery lesions treated with IVL, intravascular ultrasound-guided cases were selected. CACom was calculated as the systo-diastolic change in the luminal area (ΔA), measured using intravascular ultrasound, relative to the corresponding change in aortic pressure (ΔP). Measurements were taken directly before (pre-CACom) and after (post-CACom) IVL therapy at the most calcified segment, where IVL pulses were administered. The primary end point was CACom modification (ΔCACom), defined as post-CACom - pre-CACom, with a correlation analysis between ΔCACom and new fractures as a key exploratory aim. Secondary analysis included assessing whether ΔCACom could predict SE at the minimum stent area (MSA) and the eccentricity index.

RESULTS

Coronary artery compliance significantly improved after IVL therapy (median ΔCACom 0.33 [0.19-0.70] mm/mm Hg; < .01). Lesions showing new calcium fractures presented significantly greater ΔCACom compared to those without. ΔCACom and new calcium fractures were significantly correlated (R = 0.466; < .01). In univariate analysis, ΔCACom was found to be a significant predictor for SE at MSA ( < .01), MSA ( = .015), and SE >80% ( = .025), but not eccentricity index ( = .157). At multivariate analysis, ΔCACom was an independent predictor of SE (R = 0.420; = .044) and SE >80% at MSA (OR, 6.58 [1.24-34.90]; = .043).

CONCLUSIONS

In heavily calcified coronary lesions treated with IVL, ΔCACom is an independent predictor of SE.

摘要

背景

血管内碎石术(IVL)已被证明可有效治疗球囊可通过的钙化冠状动脉病变,其通过诱导钙骨折并促进支架扩张(SE),理论上是通过改善冠状动脉顺应性(CACom)来实现的。该理论的直接证据尚未得到证实。

方法

从比荷卢经济联盟-IVL前瞻性注册研究(NCT06577038)中选取接受IVL治疗的钙化冠状动脉病变患者的血管内超声引导病例。CACom通过血管内超声测量的管腔面积的收缩-舒张变化(ΔA)相对于主动脉压力的相应变化(ΔP)来计算。在给予IVL脉冲的最钙化节段,在IVL治疗前(CACom前)和治疗后(CACom后)直接进行测量。主要终点是CACom改变(ΔCACom),定义为CACom后 - CACom前,以ΔCACom与新骨折之间的相关性分析作为关键探索性目标。次要分析包括评估ΔCACom是否可以预测最小支架面积(MSA)处的SE和偏心指数。

结果

IVL治疗后冠状动脉顺应性显著改善(中位ΔCACom 0.33 [0.19 - 0.70] mm/mm Hg;P <.01)。与没有新钙骨折的病变相比,出现新钙骨折的病变表现出显著更大的ΔCACom。ΔCACom与新钙骨折显著相关(R = 0.466;P <.01)。在单变量分析中,发现ΔCACom是MSA处SE(P <.01)、MSA(P =.015)和SE > 80%(P =.025)的显著预测因子,但不是偏心指数(P =.157)的预测因子。在多变量分析中,ΔCACom是SE(R = 0.420;P =.044)和MSA处SE > 80%(OR,6.58 [1.24 - 34.90];P =.043)的独立预测因子。

结论

在接受IVL治疗的重度钙化冠状动脉病变中,ΔCACom是SE的独立预测因子。

相似文献

1
Coronary Compliance Modification by Intravascular Lithotripsy: New Predictor of Stent Expansion in Calcified Coronary Lesions.血管内超声碎石术对冠状动脉顺应性的改善:钙化冠状动脉病变中支架扩张的新预测指标
J Soc Cardiovasc Angiogr Interv. 2025 May 1;4(5):102635. doi: 10.1016/j.jscai.2025.102635. eCollection 2025 May.
2
Coronary intravascular lithotripsy in contemporary practice: challenges and opportunities in coronary intervention.经皮冠状动脉腔内碎石术在当代实践中的应用:冠状动脉介入治疗中的挑战与机遇。
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241263444. doi: 10.1177/17539447241263444.
3
Intravascular Lithotripsy for the Treatment of Severely Calcified Coronary Artery Disease: A DISRUPT CAD III Intravascular Ultrasound Substudy.血管内碎石术治疗严重钙化冠状动脉疾病:DISRUPT CAD III 血管内超声子研究。
Cardiovasc Revasc Med. 2023 Aug;53:22-27. doi: 10.1016/j.carrev.2023.03.003. Epub 2023 Mar 11.
4
Treatment of severe coronary artery calcification with intravascular lithotripsy: Initial experience of a prospective single centre registry.经血管内碎石术治疗严重冠状动脉钙化:前瞻性单中心注册研究的初步经验。
Med J Malaysia. 2022 Jul;77(4):500-505.
5
Intravascular Imaging to Guide Lithotripsy in Concentric and Eccentric Calcific Coronary Lesions.血管内影像学指导同心性和偏心性钙化冠状动脉病变的碎石术。
Cardiovasc Revasc Med. 2020 Sep;21(9):1099-1105. doi: 10.1016/j.carrev.2020.04.016. Epub 2020 Apr 16.
6
Safety, efficacy, and optical coherence tomography insights into intravascular lithotripsy for the modification of non-eruptive calcified nodules: A prospective observational study.经血管内碎石术治疗未破裂钙化结节的安全性、有效性及光相干断层扫描研究:一项前瞻性观察研究。
Catheter Cardiovasc Interv. 2024 Oct;104(4):688-696. doi: 10.1002/ccd.31217. Epub 2024 Sep 3.
7
IntravaScular Lithotripsy for the Management of UndILatable Coronary StEnt: The SMILE Registry.血管内碎石术治疗不可扩张的冠状动脉支架:SMILE 登记研究。
Cardiovasc Revasc Med. 2020 Dec;21(12):1555-1559. doi: 10.1016/j.carrev.2020.05.020. Epub 2020 May 23.
8
Retrospective Multicenter Analysis of Intravascular Lithotripsy Use During Calcified Left Main Coronary Artery Percutaneous Coronary Interventions.钙化左主干冠状动脉经皮冠状动脉介入治疗中血管内碎石术应用的回顾性多中心分析
J Soc Cardiovasc Angiogr Interv. 2023 Nov 10;3(2):101213. doi: 10.1016/j.jscai.2023.101213. eCollection 2024 Feb.
9
Intravascular Lithotripsy in Calcified Coronary Lesions: A Prospective, Observational, Multicenter Registry.血管内碎石术治疗钙化性冠状动脉病变:一项前瞻性、观察性、多中心登记研究。
Circ Cardiovasc Interv. 2019 Nov;12(11):e008154. doi: 10.1161/CIRCINTERVENTIONS.119.008154. Epub 2019 Nov 11.
10
Comparison of Coronary Intravascular Lithotripsy and Rotational Atherectomy in the Modification of Severely Calcified Stenoses.冠状动脉内旋磨术与旋切术治疗严重钙化狭窄病变的比较。
Am J Cardiol. 2023 Jun 15;197:93-100. doi: 10.1016/j.amjcard.2023.02.028. Epub 2023 Apr 2.

引用本文的文献

1
Intravascular lithotripsy for the treatment of calcified coronary lesions in individuals of advanced age: a post-hoc analysis of the multicentre, prospective BENELUX-IVL study.血管内碎石术治疗高龄患者钙化性冠状动脉病变:多中心前瞻性比荷卢血管内碎石术(BENELUX-IVL)研究的事后分析
EClinicalMedicine. 2025 Jul 4;85:103342. doi: 10.1016/j.eclinm.2025.103342. eCollection 2025 Jul.

本文引用的文献

1
Evolving use and clinical outcomes of coronary intravascular lithotripsy: insights from an international, multicentre registry.冠状动脉血管内碎石术的应用进展及临床结果:来自一项国际多中心注册研究的见解
Heart. 2024 Dec 23;111(2):62-68. doi: 10.1136/heartjnl-2024-324703.
2
Invasive evaluation of coronary artery compliance modification after intracoronary lithotripsy.冠状动脉内碎石术后冠状动脉顺应性改变的有创评估
J Cardiovasc Med (Hagerstown). 2024 Sep 1;25(9):715-716. doi: 10.2459/JCM.0000000000001643. Epub 2024 Jul 22.
3
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group.
重度钙化冠状动脉狭窄的处理策略:EAPCI 与 EURO4C-PCR 协作组联合发布的临床共识声明。
Eur Heart J. 2023 Nov 1;44(41):4340-4356. doi: 10.1093/eurheartj/ehad342.
4
Intravascular Ultrasound-Derived Calcium Score to Predict Stent Expansion in Severely Calcified Lesions.血管内超声衍生的钙评分预测严重钙化病变中的支架扩张。
Circ Cardiovasc Interv. 2021 Oct;14(10):e010296. doi: 10.1161/CIRCINTERVENTIONS.120.010296. Epub 2021 Oct 19.
5
Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions: Patient-Level Pooled Analysis of the Disrupt CAD Studies.血管内碎石术治疗钙化性冠状动脉病变:Disrupt CAD 研究的患者水平汇总分析。
JACC Cardiovasc Interv. 2021 Jun 28;14(12):1337-1348. doi: 10.1016/j.jcin.2021.04.015. Epub 2021 May 3.
6
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.冠状动脉内影像学的临床应用。第 1 部分:冠状动脉介入治疗的指导和优化。欧洲经皮心血管介入治疗协会的专家共识文件。
Eur Heart J. 2018 Sep 14;39(35):3281-3300. doi: 10.1093/eurheartj/ehy285.
7
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial.在 ABSORB II 试验中,生物可吸收依维莫司洗脱支架和金属依维莫司洗脱支架的术后对称性、扩张和偏心对临床结果的影响。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1231-1242. doi: 10.1016/j.jcin.2016.03.027. Epub 2016 Jun 1.
8
Coronary endothelial dysfunction is associated with a reduction in coronary artery compliance and an increase in wall shear stress.冠状动脉内皮功能障碍与冠状动脉顺应性降低和壁切应力增加有关。
Heart. 2010 May;96(10):773-8. doi: 10.1136/hrt.2009.187898.
9
Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation.西罗莫司洗脱支架植入术后血管造影再狭窄的血管内超声预测因素
Eur Heart J. 2006 Jun;27(11):1305-10. doi: 10.1093/eurheartj/ehi882. Epub 2006 Apr 27.
10
Nitric oxide regulates local arterial distensibility in vivo.一氧化氮在体内调节局部动脉扩张性。
Circulation. 2002 Jan 15;105(2):213-7. doi: 10.1161/hc0202.101970.